Roth Capital Has Positive Estimate for Celsius Q1 Earnings

Celsius Holdings, Inc. (NASDAQ:CELH) – Equities researchers at Roth Capital raised their Q1 2025 EPS estimates for Celsius in a research note issued on Monday, December 16th. Roth Capital analyst S. Mcgowan now forecasts that the company will post earnings of $0.22 per share for the quarter, up from their prior estimate of $0.21. The consensus estimate for Celsius’ current full-year earnings is $0.69 per share. Roth Capital also issued estimates for Celsius’ Q2 2025 earnings at $0.26 EPS and Q3 2025 earnings at $0.19 EPS.

CELH has been the topic of several other research reports. Truist Financial upped their target price on Celsius from $30.00 to $35.00 and gave the company a “hold” rating in a research report on Wednesday, October 16th. LADENBURG THALM/SH SH cut their target price on shares of Celsius from $72.00 to $68.00 and set a “neutral” rating on the stock in a research note on Monday, October 21st. Bank of America decreased their target price on Celsius from $32.00 to $26.00 and set an “underperform” rating for the company in a research report on Thursday, September 5th. Stifel Nicolaus cut their target price on Celsius from $51.00 to $45.00 and set a “buy” rating on the stock in a report on Thursday, November 7th. Finally, B. Riley lowered their price objective on shares of Celsius from $50.00 to $47.00 and set a “buy” rating on the stock in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, Celsius has an average rating of “Moderate Buy” and a consensus price target of $51.17.

Celsius Stock Performance

Shares of NASDAQ CELH opened at $29.24 on Wednesday. The company’s 50 day moving average price is $30.10 and its 200-day moving average price is $40.47. Celsius has a 52-week low of $25.23 and a 52-week high of $99.62. The company has a market capitalization of $6.87 billion, a P/E ratio of 40.61, a price-to-earnings-growth ratio of 3.44 and a beta of 1.76.

Institutional Investors Weigh In On Celsius

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CELH. Livforsakringsbolaget Skandia Omsesidigt bought a new stake in Celsius in the 3rd quarter worth approximately $34,000. Signaturefd LLC increased its position in Celsius by 48.3% in the third quarter. Signaturefd LLC now owns 1,160 shares of the company’s stock worth $36,000 after purchasing an additional 378 shares during the last quarter. Benjamin F. Edwards & Company Inc. raised its stake in Celsius by 353.1% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 648 shares of the company’s stock valued at $37,000 after purchasing an additional 505 shares in the last quarter. Newbridge Financial Services Group Inc. lifted its position in Celsius by 3,150.0% during the second quarter. Newbridge Financial Services Group Inc. now owns 650 shares of the company’s stock valued at $37,000 after purchasing an additional 630 shares during the last quarter. Finally, Activest Wealth Management purchased a new position in shares of Celsius in the 3rd quarter worth $39,000. 60.95% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Celsius

In other Celsius news, major shareholder William H. Milmoe sold 65,000 shares of the company’s stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $31.15, for a total transaction of $2,024,750.00. Following the completion of the sale, the insider now directly owns 261,245 shares of the company’s stock, valued at approximately $8,137,781.75. This represents a 19.92 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.20% of the company’s stock.

Celsius Company Profile

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.